Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Nahon

Showing results (81-90 of 205) with videos related to

Pageof 21
Sort By:
Antioxidants & Redox Signaling|July 20, 2011
Lipopolysaccharide-induced mitochondrial DNA depletionAmal Choumar, Arige Tarhuni, Philippe Lettéron, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 26, 2011
Chemokine RANTES promoter dimorphisms and hepatocellular carcinoma occurrence in patients with alcoholic or hepatitis C virus-related cirrhosisFaten Charni, Angela Sutton, Pierre Rufat, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 20, 2021
HCV Eradication in Primary or Secondary Prevention Optimizes Hepatocellular Carcinoma Curative ManagementPierre Nahon, Richard Layese, Carole Cagnot, et al.
World Journal of Gastroenterology|September 23, 2008
Liver insulin-like growth factor 2 methylation in hepatitis C virus cirrhosis and further occurrence of hepatocellular carcinomaPhilippe Couvert, Alain Carrié, Jacques Pariès, et al.
Free Radical Biology & Medicine|September 2, 2008
The manganese superoxide dismutase Ala16Val dimorphism modulates iron accumulation in human hepatoma cellsPierre Nahon, Nathalie Charnaux, Véronique Friand, et al.
Liver Cancer|June 14, 2019
Multibipolar Radiofrequency Ablation for the Treatment of Mass-Forming and Infiltrative Hepatocellular Carcinomas > 5 cm: Long-Term ResultsGisele N'Kontchou, Jean-Charles Nault, Olivier Sutter, et al.
JHEP Reports : Innovation in Hepatology|November 11, 2024
Heterogeneity in adverse events related to atezolizumab-bevacizumab for hepatocellular carcinoma reported in real-world studiesClaudia Campani, Dimitrios Pallas, Sabrina Sidali, et al.
Journal of Hepatology|October 22, 2008
Assessment of liver fibrosis using transient elastography in patients with alcoholic liver diseasePierre Nahon, Adrien Kettaneh, Iulia Tengher-Barna, et al.
Journal of Hepatology|October 17, 2012
PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosisErwan Guyot, Angela Sutton, Pierre Rufat, et al.
European Cytokine Network|December 15, 2018
Elevated adiponectin and sTNFRII serum levels can predict progression to hepatocellular carcinoma in patients with compensated HCV1 cirrhosisJean-Philippe Bastard, Soraya Fellahi, Étienne Audureau, et al.
Pageof 21

Showing results (81-90 of 205) with videos related to

Sort By:
Pageof 21
Antioxidants & Redox Signaling|July 20, 2011
Lipopolysaccharide-induced mitochondrial DNA depletionAmal Choumar, Arige Tarhuni, Philippe Lettéron, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 26, 2011
Chemokine RANTES promoter dimorphisms and hepatocellular carcinoma occurrence in patients with alcoholic or hepatitis C virus-related cirrhosisFaten Charni, Angela Sutton, Pierre Rufat, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 20, 2021
HCV Eradication in Primary or Secondary Prevention Optimizes Hepatocellular Carcinoma Curative ManagementPierre Nahon, Richard Layese, Carole Cagnot, et al.
World Journal of Gastroenterology|September 23, 2008
Liver insulin-like growth factor 2 methylation in hepatitis C virus cirrhosis and further occurrence of hepatocellular carcinomaPhilippe Couvert, Alain Carrié, Jacques Pariès, et al.
Free Radical Biology & Medicine|September 2, 2008
The manganese superoxide dismutase Ala16Val dimorphism modulates iron accumulation in human hepatoma cellsPierre Nahon, Nathalie Charnaux, Véronique Friand, et al.
Liver Cancer|June 14, 2019
Multibipolar Radiofrequency Ablation for the Treatment of Mass-Forming and Infiltrative Hepatocellular Carcinomas > 5 cm: Long-Term ResultsGisele N'Kontchou, Jean-Charles Nault, Olivier Sutter, et al.
JHEP Reports : Innovation in Hepatology|November 11, 2024
Heterogeneity in adverse events related to atezolizumab-bevacizumab for hepatocellular carcinoma reported in real-world studiesClaudia Campani, Dimitrios Pallas, Sabrina Sidali, et al.
Journal of Hepatology|October 22, 2008
Assessment of liver fibrosis using transient elastography in patients with alcoholic liver diseasePierre Nahon, Adrien Kettaneh, Iulia Tengher-Barna, et al.
Journal of Hepatology|October 17, 2012
PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosisErwan Guyot, Angela Sutton, Pierre Rufat, et al.
European Cytokine Network|December 15, 2018
Elevated adiponectin and sTNFRII serum levels can predict progression to hepatocellular carcinoma in patients with compensated HCV1 cirrhosisJean-Philippe Bastard, Soraya Fellahi, Étienne Audureau, et al.
Pageof 21